BLTE Belite Bio, Inc.
Belite Bio, Inc. (BLTE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 92% planned / 8% discretionary
Largest single sale: $2.1M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Lin Yu-Hsin 5 fills | Chief Executive Officer | Sell 10b5-1 | 26,000 | $196.56 | $5.1M | 93,734 −21.7% of holding | |
| Chuang Hao-Yuan 5 fills | Chief Financial Officer | Sell 10b5-1 | 17,962 | $196.42 | $3.5M | 41,800 −30.1% of holding | |
| Lin Yu-Hsin 14 fills | Chief Executive Officer | Sell 10b5-1 | 74,435 | $187.71 | $14.0M | 167,934 −30.7% of holding | |
| Chuang Hao-Yuan 14 fills | Chief Financial Officer | Sell 10b5-1 | 49,433 | $187.64 | $9.3M | 91,800 −35% of holding | |
| Chuang Hao-Yuan 2 fills | Chief Financial Officer | Sell 10b5-1 | 367 | $180.35 | $66.2K | 93,656 −0.4% of holding | |
| Lin Yu-Hsin 2 fills | Chief Executive Officer | Sell 10b5-1 | 365 | $180.35 | $65.8K | 170,792 −0.2% of holding | |
| Scholl Hendrik Peter 5 fills | Chief Medical Officer | Sell | 10,000 | $145.24 | $1.5M | 24,904 −28.7% of holding | |
| Scholl Hendrik Peter 8 fills | Chief Medical Officer | Sell | 10,000 | $140.57 | $1.4M | 32,946 −23.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.